Events

VB2010 – Vancouver, Canada

This year the Virus Bulleting Conference, one of the most prestigious annual events in the anti-virus industry, took place in Vancouver, Canada.

It was a special event for Kaspersky Lab since we had a record-breaking total of seven speakers: who covered the most interesting and hot topics such as mobile malware, on-line fraud and black markets, targeted attacks. Last, but not least, we were able to reveal some new details about Stuxnet in a joint presentation with Microsoft. The VB conference demonstrated again how important cooperation between researchers is. Between the joint work on Stuxnet and the Zeus-related arrests we saw how AV researchers from different countries; cultures and companies join forces to fight cyber crime and to make this world safer.

Every year the AV community gathers at VB – next year it will be in Barcelona, Spain and I hope we will also have good news to share again.

PS We will be posting the Kaspersky VB papers online over the next few days here http://www.kaspersky.com/VB_2010

VB2010 – Vancouver, Canada

Your email address will not be published. Required fields are marked *

 

Reports

Operation TunnelSnake

A newly discovered rootkit that we dub ‘Moriya’ is used by an unknown actor to deploy passive backdoors on public facing servers, facilitating the creation of a covert C&C communication channel through which they can be silently controlled. The victims are located in Africa, South and South-East Asia.

APT trends report Q1 2021

This report highlights significant events related to advanced persistent threat (APT) activity observed in Q1 2021. The summaries are based on our threat intelligence research and provide a representative snapshot of what we have published and discussed in greater detail in our private APT reports.

The leap of a Cycldek-related threat actor

The investigation described in this article started with one such file which caught our attention due to the various improvements it brought to this well-known infection vector.

Subscribe to our weekly e-mails

The hottest research right in your inbox